2019 International Congress Archives - Page 130 of 217

Waiting and waiting on Dopamine transporter imaging in drug induced parkinsonism

JY. Yun, CY. Lee, MY. Chun, B. Jeon (Seoul, Republic of Korea)
Wearable sensor use and monitoring effect of dopamine replacement therapy on motor parameters in a real life clinical setting

A. Podlewska, D. van Wamelen, A. Sauerbier, V. Leta, D. Trivedi, M. Parry, K. Ray Chaudhuri (Lodnon, United Kingdom)
Wearable versus marker-free technologies: does it matter for clinical gait analysis?

K. Otte, D. Drebinger, H. Röhling, T. Vater, D. Kroneberg, M. Voigt, B. Kayser, S. Mansow-Model, AU. Brandt, F. Paul, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)
Weighting fibroblasts for future diagnostic prospect

G. Prevot, E. Bezard, L. Cognet, B. Dehay, P. Bon (Bordeaux, France)
WES analysis of Parkinson’s disease patients with Cancer

Y. Gao, G. Wang, X. Xie (Shanghai, China)
What can predict short and long-term outcome of bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease?

F. Cavallieri, V. Fraix, D. Mulas, F. Bove, M. Tondelli, P. Pélissier, A. Castrioto, S. Meoni, E. Schmitt, E. Chevrier, E. Lhommée, A. Bichon, A. Kistner, C. Ardouin, P. Limousin, S. Chabardès, AL. Benabid, E. Seigneuret, P. Krack, P. Pollak, E. Moro (Grenoble, France)
What connectivity tells us about neurodegeneration in Huntington disease? A fMRI study

P. de Azevedo, M. Nogueira, L. Ribeiro, B. de Campos, R. Guimarães, L. Piovesana, F. Cendes, I. Lopes-Cendes, C. Yasuda (Campinas, Brazil)
What do medical students think about functional movement disorders?

JB. Paredes, E. Villalba, A. Canovas, JL. Sendon, P. Torre, S. Argos, S. Madrona, J. Poles, V. Hristova, L. García, JC. Castrillo, I. Moreno (Madrid, Spain)
What patients need – a qualitative analysis of consultations prior to deep brain stimulation in patients with Parkinson’s disease

R. Dano, JN. Petry-Schmelzer, J. Steffen, G. Fink, M. Barbe (Cologne, Germany)
White matter abnormalities correlate with clinical features in PSP patients

A. Campabadal, A. Abos, B. Segura, HC. Baggio, C. Uribe, A. Garrido, A. Camara, E. Muñoz, F. Valldeoriola, MJ. Martí, C. Junqué, Y. Compta (Barcelona, Spain)
White matter and subcortical volume of essential tremor patient decreases after MR-guided focused ultrasound thalamotomy

K. Tsai, HC. Lai, CY. Wei, PY. Chiu, W. Lin, CL. Chen, SK. Yang, CH. Hung, WC. Chang (Changhua County, Taiwan)
Whole Exome Sequencing Identifies a Homozygous POLG2 Missense Variant in an adult patient presenting with movement disorders and Mitochondrial DNA Depletion

P. Dosekova, V. Habalova, M. Skirkova, V. Han, A. Mosejova, Z. Gdovinova, M. Skorvanek, R. Ploski (Kosice, Slovakia)
Whole-Body Neuromuscular Ultrasound for Evaluating Posture and Targeted Management of Muscle Spasticity and Pain

R. Bubnov, L. Kalika (Kyiv, Ukraine)
Wide distribution of alpha-synuclein oligomers in Creutzfeldt-Jakob disease detected by a novel proximity ligation assay

R. Valenti-Azcarate, I. Martinez-Valbuena, C. Caballero, I. Marcilla Garcia, G. Marti, M. Carmona-Abellan, M. Tuñon-Alvarez, MR. Luquin-Piudo (Pamplona, Spain)
Widespread distribution and abundant accumulation of alpha-synuclein oligomers in multiple system atrophy brain

H. Sekiya, H. Kowa, H. Koga, M. Takata, W. Satake, N. Futamura, I. Funakawa, K. Jinnai, M. Kanagawa, K. Kobayashi, T. Toda (Kobe, Japan)
Wilson disease: a systematic review and meta-analysis in phenotype – genotype correlations

M. Ruiz-Lopez, A. Abrahao, ME. Freitas, J. Trinh, S. Fox (Madrid, Spain)
Wilson’s disease in Finland

J. Sipilä, M. Hietala, V. Kaasinen (Joensuu, Finland)
Wislon disease: clinical specificities of the disease course under normal ceruloplasmin in the blood, a clinical case from Kyrgyzstan

N. Chekeeva (Bishkek, Kyrgyzstan)